Skip to content

Clinical Trial on the Methodology of Hysterosalpingography: a Comparative Study

Clinical Trial on the Methodology of Hysterosalpingography: a Comparative Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07583758
Acronym
MethodHSG
Enrollment
251
Registered
2026-05-13
Start date
2020-01-01
Completion date
2026-04-25
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterosalpingography, Infertility

Keywords

hysterosalpingography, metal cannula, active balloon, passive balloon, infertility

Brief summary

Different techniques have been developed to optimize hysterosalpingography (HSG) methodology. Our aim is to compare the advantages and disadvantages of these three different techniques in terms of both patient satisfaction and clinician's interpretation. The medical records of the patients who are treated in our hospital between 2020 and 2022 are investigated based on the eligibility criteria.

Interventions

DIAGNOSTIC_TESTHysterosalpingography - Metal Cannula Method

Different techniques of hysterosalpingography (HSG) were applied for 3 groups in parallel.

DIAGNOSTIC_TESTHysterosalpingography - Active Balloon Method

Different techniques of hysterosalpingography (HSG) were applied for 3 groups in parallel.

DIAGNOSTIC_TESTHysterosalpingography - Passive Balloon Method

Different techniques of hysterosalpingography (HSG) were applied for 3 groups in parallel.

Sponsors

Medipol University
Lead SponsorOTHER
Istanbul Medipol University Hospital
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Masking description

The patients didn't know which methodology will be applied.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

\- Female patients with infertility

Exclusion criteria

* Male patients * Patients who are diagnosed with menopause * Patients who do not want to proceed with HSG for diagnosis purposes

Design outcomes

Primary

MeasureTime frameDescription
Patient SatisfactionDay 1Patients' visual analogue scores (VAS) immediately after the procedure and 30 minutes post-procedure are recorded, respectively. The pain is assessed by the principal investigator. The visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').
Clinician's InterpretationDay 1The interpretation is classified as "clearly evaluated", "partially evaluated" and as "could not be evaluated" by the clinician.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORGulseren Polat, M.D.

Medipol University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026